chrX-31223056-C-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_004006.3(DMD):c.9352G>T(p.Ala3118Ser) variant causes a missense change. The variant allele was found at a frequency of 0.0000348 in 1,207,203 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 15 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.000036 ( 0 hom., 1 hem., cov: 23)
Exomes 𝑓: 0.000035 ( 0 hom. 14 hem. )
Consequence
DMD
NM_004006.3 missense
NM_004006.3 missense
Scores
1
3
12
Clinical Significance
Conservation
PhyloP100: 6.92
Genes affected
DMD (HGNC:2928): (dystrophin) This gene spans a genomic range of greater than 2 Mb and encodes a large protein containing an N-terminal actin-binding domain and multiple spectrin repeats. The encoded protein forms a component of the dystrophin-glycoprotein complex (DGC), which bridges the inner cytoskeleton and the extracellular matrix. Deletions, duplications, and point mutations at this gene locus may cause Duchenne muscular dystrophy (DMD), Becker muscular dystrophy (BMD), or cardiomyopathy. Alternative promoter usage and alternative splicing result in numerous distinct transcript variants and protein isoforms for this gene. [provided by RefSeq, Dec 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.3787263).
BS2
High Hemizygotes in GnomAdExome4 at 14 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DMD | NM_004006.3 | c.9352G>T | p.Ala3118Ser | missense_variant | 64/79 | ENST00000357033.9 | NP_003997.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DMD | ENST00000357033.9 | c.9352G>T | p.Ala3118Ser | missense_variant | 64/79 | 1 | NM_004006.3 | ENSP00000354923.3 |
Frequencies
GnomAD3 genomes AF: 0.0000357 AC: 4AN: 112027Hom.: 0 Cov.: 23 AF XY: 0.0000293 AC XY: 1AN XY: 34187
GnomAD3 genomes
AF:
AC:
4
AN:
112027
Hom.:
Cov.:
23
AF XY:
AC XY:
1
AN XY:
34187
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000436 AC: 8AN: 183500Hom.: 0 AF XY: 0.0000294 AC XY: 2AN XY: 67936
GnomAD3 exomes
AF:
AC:
8
AN:
183500
Hom.:
AF XY:
AC XY:
2
AN XY:
67936
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000347 AC: 38AN: 1095176Hom.: 0 Cov.: 29 AF XY: 0.0000388 AC XY: 14AN XY: 360614
GnomAD4 exome
AF:
AC:
38
AN:
1095176
Hom.:
Cov.:
29
AF XY:
AC XY:
14
AN XY:
360614
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000357 AC: 4AN: 112027Hom.: 0 Cov.: 23 AF XY: 0.0000293 AC XY: 1AN XY: 34187
GnomAD4 genome
AF:
AC:
4
AN:
112027
Hom.:
Cov.:
23
AF XY:
AC XY:
1
AN XY:
34187
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
2
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:5Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Duchenne muscular dystrophy Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Pars Genome Lab | May 18, 2021 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 06, 2023 | - - |
Duchenne muscular dystrophy;C0917713:Becker muscular dystrophy;C3668940:Dilated cardiomyopathy 3B Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 31, 2018 | - - |
Primary familial dilated cardiomyopathy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart Institute | Jul 18, 2017 | - - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Athena Diagnostics | Jan 03, 2020 | - - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 26, 2021 | The p.A3118S variant (also known as c.9352G>T), located in coding exon 64 of the DMD gene, results from a G to T substitution at nucleotide position 9352. The alanine at codon 3118 is replaced by serine, an amino acid with similar properties. This amino acid position is highly conserved in available vertebrate species. Based on data from gnomAD, the T allele has an overall frequency of 0.004% (8/183500) total alleles studied, with 2 hemizygote(s) observed. The highest observed frequency was 0.01% (8/81942) of non-Finnish European alleles. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
.;.;T;T;T;.;.;T;.;.;.;T;.;.
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;.;.;.;.;D;.;D;D;D;.;D;D
M_CAP
Benign
D
MetaRNN
Benign
T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
T
PrimateAI
Pathogenic
D
PROVEAN
Benign
N;N;.;N;N;N;.;N;.;N;N;N;N;N
REVEL
Benign
Sift
Benign
T;T;.;T;T;T;.;T;.;T;T;T;T;T
Sift4G
Benign
T;T;T;T;T;T;T;T;T;T;T;T;T;T
Polyphen
0.33, 0.14, 0.0010, 0.98, 0.97
.;.;.;B;B;B;.;D;.;.;.;B;D;.
Vest4
MutPred
0.51
.;.;.;.;.;.;.;.;.;Gain of disorder (P = 0.0687);.;.;.;.;
MVP
MPC
0.035
ClinPred
T
GERP RS
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at